COMMUNIQUÉS West-GlobeNewswire

ACARIZAX® approved in Canada for treatment of young children

07/03/2025 - 14:34

ALK ( ALKB:DC / OMX: ALK B ) today announced that Health Canada has approved ALK’s ACARIZAX ® tablet for use in children, aged five to 11, with house dust mite (HDM) allergy. ACARIZAX ® is now indicated for treatment of [...]

COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

07/03/2025 - 14:37

Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security Sectors WEXFORD, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (Nasdaq: COEP) ("the Company" or "COEPTIS"), a [...]

ICU Medical to Participate at the KeyBanc Healthcare Forum

07/03/2025 - 14:40

SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will [...]

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

07/03/2025 - 14:45

First-ever HPV16-positive head and neck cancer Phase 3 clinical trial PRINCETON, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage [...]

Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update

07/03/2025 - 14:58

LONDON AND PHILADELPHIA, March 07, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor [...]

Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent

07/03/2025 - 15:00

Hamilton, March 07, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a patent (application #17/ [...]

Revenue Cycle Optimizations Among Nextech Enhancements on Display at AAD 2025

07/03/2025 - 15:00

Integrated Revenue Cycle Management (RCM) Enables Providers to Decrease Denied Claims and Increase Reimbursement TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Nextech, the leader in healthcare technology and practice [...]

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

07/03/2025 - 15:00

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th Annual Global [...]

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

07/03/2025 - 15:00

REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today [...]

Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting

07/03/2025 - 15:11

Shareholders approved 28 th consecutive dividend increase to CHF 3.50 (+6.1%) per share for 2024, representing a 3.5% yield¹ Shareholders elected Giovanni Caforio as new member and Chair of the Board of Directors as [...]

Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

07/03/2025 - 15:25

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]

Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts

07/03/2025 - 15:28

Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments LONDON and PHILADELPHIA, March 07, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM [...]

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

07/03/2025 - 17:00

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership [...]

NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology

07/03/2025 - 17:30

BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to [...]

Virbac : Déclaration d'actions et de droits de vote 02/2025

07/03/2025 - 17:43

DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights 02/25

07/03/2025 - 17:43

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

07/03/2025 - 18:09

Nck modulator reduced evidence of inflammation in an animal model of dermal irritation Compelling preclinical data support continued development of Nck modulators in atopic dermatitis CAMBRIDGE, Mass., March 07, 2025 ( [...]

Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering

07/03/2025 - 18:29

Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, [...]

Tsay Keh Dene Nation partners with Tersa Earth to drive sustainable mining solutions

07/03/2025 - 19:44

BURNABY, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- The Tsay Keh Dene Nation (TKDN) and Tersa Earth Innovations Inc. are pleased to announce a strategic investment and partnership focused on the future of [...]